Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a report published on Sunday morning. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Performance

Shares of NYSE:ENZ opened at $1.07 on Friday. The business’s fifty day moving average price is $1.11 and its two-hundred day moving average price is $1.11. Enzo Biochem has a fifty-two week low of $0.93 and a fifty-two week high of $1.50.

Enzo Biochem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 37.38%. The ex-dividend date of this dividend was Friday, November 15th.

Institutional Investors Weigh In On Enzo Biochem

A number of hedge funds have recently added to or reduced their stakes in ENZ. Renaissance Technologies LLC lifted its holdings in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after buying an additional 64,417 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares during the period. BBR Partners LLC bought a new position in Enzo Biochem in the third quarter valued at about $112,000. Finally, XTX Topco Ltd increased its position in Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after purchasing an additional 13,735 shares during the period. Institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.